BRIEF-Flexion Therapeutics announces FDA approval of Zilretta for osteoarthritis knee pain
October 06, 2017 at 15:11 PM EDT
* Flexion Therapeutics announces FDA approval of Zilretta (triamcinolone acetonide extended-release injectable suspension) for osteoarthritis (OA) knee pain